Перегляд Experimental Oncology, 2007, № 2 за назвою
-
Kumarappan, C.T.; Subhash C. Mandal
(Experimental Oncology, 2007)
Aim: Phytochemical and dietary antioxidants are known to decrease the risk of many diseases such as cancer and cardiovascular diseases. In this study polyphenolic extract (PPE) of leaves of Ichnocarpus frutescens was ...
-
Shen, S.; Xu, Z.; Qian, X.; Ding, Y.; Yu, L.; Liu, B.
(Experimental Oncology, 2007)
Since dendritic cells (DCs) constitute only 0.1–0.5% of human peripheral blood mononuclear cells (PBMCs), and generation of DCs from monocytes or stem cells is difficult and expensive, we choose B-lymphocytes as an ...
-
Yerushalmi, R.; Nordenberg, J.; Beery, E.; Uziel, O.; Lahav, M.; Luria, D.; Fenig, E.
(Experimental Oncology, 2007)
Little is known about the interaction of novel anticancer drugs with other treatment modalities. The aim of this study was to examine the effect of combining imatinib mesylate (STI-571) with radiation or cisplatin on the ...
-
Kusumoto, K.; Kageyama, K.; Matsuda, T.; Tomura, T.T.; Munakata, H.; Tanaka, H.; Yazama, F.; Miwa, N.
(Experimental Oncology, 2007)
Aim: To evaluate promotive effect of hyperthermia on the carcinostatic activity of synthesized omega-hydroxy fatty acids (wHFAs) and their ethylesters agaist Ehrlich ascites tumor (EAT) cells. Methods: EAT cells were ...
-
Potebnya, G.P.; Kudryavets, Yu.Y.; Lisovenko, G.S.; Cheremshenko, N.L.; Voeykova, I.M.; Trokhimenko, N.V.; Symchich, T.V.; Evstrateyva, L.M.
(Experimental Oncology, 2007)
Aim: To study in in vivo model the efficacy of combined scheme of administration of cancer vaccine (CV) and interferon (IFN). Materials and Methods: Lewis lung carcinoma (LLC) was transplanted to male C57Bl mice. For ...
-
Domenyuk, V.P.; Litovkin, K.V.; Verbitskaya, T.G.; Dubinina, V.G.; Bubnov, V.V.
(Experimental Oncology, 2007)
Aim: To identify clinically significant molecular markers of endometrial cancer. Materials and Methods: Cancer and normal endometrial tissue samples from 20 patients of the Gynecology Clinic of Odessa State Medical University ...
-
Cinek, P.; Filip, S.; Vaňásek, J.; Měřička, P.; Bláha, M.; Zouhar, M.
(Experimental Oncology, 2007)
Aim: The main aim of our paper is to contribute to objectification of currently widely discussed results of overall survival (OS), disease free survival (DFS) and time from relapse to tumor progression (TTP) in women with ...
-
Chen, L.J.; Li, J.Y.; Xu, W.; Qiu, H.R.; Zhu, Y.; Zhang, Y.P.; Duan, L.M.; Qian, S.X.; Lu, H.
(Experimental Oncology, 2007)
Background: Multiple myeloma (MM) is an incurable hematological disorder characterized by the accumulation of malignant plasma cells within the bone marrow (BM). The clinical heterogeneity of MM is dictated by the cytogenetic ...
-
Golias, Ch.; Charalabopoulos, A.; Stagikas, D.; Giannakopoulos, X.; Peschos, D.; Batistatou, A.; Sofikitis, N.; Charalabopoulos, K.
(Experimental Oncology, 2007)
In the present review article a global approach regarding the usefulness of genomic microarrays in prostate cancer management, is attempted. Cancer is a multistep process of mutations in key regulatory genes and epigenetic ...
-
Zhang, H.; Wen, Y.J.; Mao, B.Y.; Gong, Q.Y.; Qian, Z.Y.; Wei, Y.Q.
(Experimental Oncology, 2007)
Aim: Oncolytic effect of vesicular stomatitis virus (VSV) has been proved previously. Aim of the study is to investigate glioma inhibition effect of Matrix (M) protein of VSV in situ. Materials and Methods: A recombinant ...
-
Naumnik, W.; Iżycki, T.; Ossolińska, M.; Chyczewska, E.
(Experimental Oncology, 2007)
The aim of this study was to assess the clinical usefulness of determination of soluble Fas (sFas) and soluble Fas Ligand (sFasL) during chemotherapy of lung cancer. Methods: The study included 80 patients (69 males; 11 ...
-
Alexandroff, A.B.; Gibbs, S.
(Experimental Oncology, 2007)
-
Liguang, Z.; Peishu, L.; Hongluan, M.; Hong, J.; Rong, W.; Wachtel, M.S.; Frezza, E.E.
(Experimental Oncology, 2007)
Aim: To examine the expression of survivin in benign ovarian tumors, ovarian carcinomas of different stages. Methods: We screened the expression of survivin mRNA by reverse transcription polymerase chain reaction in 114 ...
-
Papa, M.L.; Capasso, F.; Pudore, L.; Torre, S.; Mango, S.; Russo, V.; Delrio, P.; Palaia, R.; Ruffolo, F.; d’Eufemia, M.D.; De Lucia, D.; Napolitano, M.; Di Micco, P.; Parisi, V.
(Experimental Oncology, 2007)
Background: Quantification of the magnitude of thrombotic risk associated with malignancy and with anti-cancer therapy is indispensable to use anticoagulant drugs which selectively interfere with haemostatic mechanisms ...